Suchergebnisse - "Sargos, Paul"

PubPharm (160)

41

Perioperative outcomes after radical prostatectomy : does the surgical approach change the impact of hospital volume? A nationwide analysis

enthalten in: Minerva urology and nephrology | 2022

von Baboudjian, M. | Gondran-Tellier, B. | Grabia, A. | +16

42

Bone Uptake in Prostate Cancer Patients : Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68 Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence

enthalten in: Clinical nuclear medicine | 2022

von Letang, A. | Crombé, A. | Rousseau, C. | +4

43

Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis

enthalten in: World journal of urology | 2022

von Dariane, C. | Ploussard, G. | Barret, E. | +12

44

Vasectomy and Risk of Prostate Cancer : A Systematic Review and Meta-analysis

enthalten in: European urology open science | 2022

von Baboudjian, M. | Rajwa, P. | Barret, E. | +15

45

Deep radiomic signature with immune cell markers predicts the survival of glioma patients

enthalten in: arXiv.org | 2022

von Chaddad, A. | Zhang, P. | Rathore, S. | +3

46

Treatment related factors associated with the risk of breast radio-induced-sarcoma

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2022

von Mirjolet, C. | Diallo, I. | Bertaut, A. | +14

47

Highly hypofractionated schedules for localized prostate cancer : Recommendations of the GETUG radiation oncology group

enthalten in: Critical reviews in oncology/hematology | 2022

von Lapierre, A. | Hennequin, C. | Beneux, A. | +17

48

Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [68Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography : Impact on Disease Management

enthalten in: European urology | 2022

von Gauthé, M. | Sargos, P. | Benziane Ouaritini, N. | +14

49

Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy

enthalten in: European urology oncology | 2022

von Fischer-Valuck, B. | Patel, S. | Brenneman, R. | +15

50

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers

enthalten in: Journal of clinical medicine | 2022

von Teyssonneau, D. | Thiery-Vuillemin, A. | Dariane, C. | +15